Lv5
1019 积分 2023-07-13 加入
Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis
14天前
已完结
Acute heart failure
14天前
已完结
Cardiometabolic shock: understanding the final turns of the downward spiral
14天前
已完结
Identification of dipeptidyl peptidase 3 as the Angiotensin-(1–7) degrading peptidase in human HK-2 renal epithelial cells
14天前
已完结
Dipeptidyl peptidase 3 induces myocardial ischemia-reperfusion injury by mediating mitophagy and the intrinsic apoptotic pathway
14天前
已完结
The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery
14天前
已完结
Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering
15天前
已完结
Lipoprotein(a) Reduction with Inclisiran, Alirocumab, Evolocumab, Enlicitide and Lerodalcibep: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
15天前
已关闭
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial
15天前
已完结
Oral PCSK9 Inhibitors
15天前
已完结
皖公网安备34019202002308
